Please login to the form below

Not currently logged in
Email:
Password:

Marathon Pharma

This page shows the latest Marathon Pharma news and features for those working in and with pharma, biotech and healthcare.

Pfizer abandons antibody for Duchenne

Pfizer abandons antibody for Duchenne

The big pharma company halted two trials of the anti-myostatin antibody, which is designed to build muscle mass and strength. ... At the moment these are the only two drugs available to treat the underlying dystrophin gene mutation in some DMD patients,

Latest news

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • A marathon and a sprint A marathon and a sprint

    It seems some pharma companies are not quite out of the starting blocks. ... Pharma’s CX marathon involves multiple participants; prescribers, policy-makers, regulators, payers, patients, carers and, as the prevention agenda gathers pace, ‘healthy’

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics